Medtronic Acquires Spinal Cord Stimulation Therapy Company
January 08 2020 - 6:29PM
Dow Jones News
By Aaron Rennie
Medtronic PLC (MDT) said Wednesday it acquired Stimgenics LLC, a
privately held company that has developed a spinal cord stimulation
therapy to treat patients with chronic pain.
Dublin-based Medtronic said the transaction is expected to be
neutral to fiscal 2020 earnings per share and meet its long-term
financial metrics for acquisitions. Additional terms of the
transaction weren't disclosed.
Randomized control trial results evaluating the Bloomington,
Ill.-based Stimgenics' Differential Target Multiplexed (DTM) Spinal
Cord Stimulation therapy versus conventional SCS will be presented
at the North American Neuromodulation Society Annual Meeting on
Jan. 23-26 in Las Vegas.
Write to Aaron Rennie at aaron.rennie@wsj.com
(END) Dow Jones Newswires
January 08, 2020 18:14 ET (23:14 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024
